COVID-19 in pulmonary critically ill patients: metagenomic identification of fungi and characterization of pathogenic microorganisms
ConclusionPatients with COVID-19 may be at increased risk of developing fungal infections as well as concurrent bacterial or viral infections, and mNGS can be a powerful tool in identifying these infections. Clinicians should be aware of the increased risk of fungal infections in COVID-19 patients, particularly those who have underlying immunocompromising conditions, and should monitor for early signs of infection.
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
More News: Aspergillosis | Aspergillus | COVID-19 | Fungal Infections | Intensive Care | Microbiology | Outbreaks | Respiratory Medicine | Study